Skip to main content
Erschienen in: Metabolic Brain Disease 6/2018

06.07.2018 | Original Article

Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases

verfasst von: D. Thirumal Kumar, Hend Ghasan Eldous, Zainab Alaa Mahgoub, C. George Priya Doss, Hatem Zayed

Erschienen in: Metabolic Brain Disease | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Gaucher’s disease (GD) is a genetic disorder in which glucocerebroside accumulates in cells and specific organs. It is broadly classified into type I, type II and type III. Patients with GD are at high risk of Parkinson’s disease (PD), and the clinical and pathological presentation of GD patients with PD is almost identical to idiopathic PD. Several experimental models like cell culture, animal models, and transgenic mice models were used to understand the molecular mechanism behind GD and PD association; however, such mechanism remains unclear. In this context, based on literature reports, we identified the most common mutations K198T, E326K, T369M, N370S, V394L, D409H, L444P, and R496H, in the Glucosylceramidase (GBA) protein that are known to cause GD1, and represent a risk of developing PD. However, to date, no computational analyses have designed to elucidate the potential functional role of GD mutations with increased risk of PD. The present computational pipeline allows us to understand the structural and functional significance of these GBA mutations with PD. Based on the published data, the most common and severe mutations were E326K, N370S, and L444P, which further selected for our computational analysis. PredictSNP and iStable servers predicted L444P mutant to be the most deleterious and responsible for the protein destabilization, followed by the N370S mutation. Further, we used the structural analysis and molecular dynamics approach to compare the most frequent deleterious mutations (N370S and L444P) with the mild mutation E326K. The structural analysis demonstrated that the location of E326K and N370S in the alpha helix region of the protein whereas the mutant L444P was in the starting region of the beta sheet, which might explain the predicted pathogenicity level and destabilization effect of the L444P mutant. Finally, Molecular Dynamics (MD) at 50 ns showed the highest deviation and fluctuation pattern in the L444P mutant compared to the two mutants E326K and N370S and the native protein. This was consistent with more loss of intramolecular hydrogen bonds and less compaction of the radius of gyration in the L444P mutant. The proposed study is anticipated to serve as a potential platform to understand the mechanism of the association between GD and PD, and might facilitate the process of drug discovery against both GD and PD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high-performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2:19–25CrossRef Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high-performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2:19–25CrossRef
Zurück zum Zitat Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the Glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351:1972–1977CrossRef Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the Glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351:1972–1977CrossRef
Zurück zum Zitat Aharon-Peretz J, Badarny S, Rosenbaum H et al (2005) Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation. Neurology 65:1460–1461CrossRef Aharon-Peretz J, Badarny S, Rosenbaum H et al (2005) Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation. Neurology 65:1460–1461CrossRef
Zurück zum Zitat Ali SK, Sneha P, Priyadharshini Christy J et al (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35:2714–2724CrossRef Ali SK, Sneha P, Priyadharshini Christy J et al (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35:2714–2724CrossRef
Zurück zum Zitat Avnir Y, Prachanronarong KL, Zhang Z et al (2017) Structural determination of the broadly reactive anti-IGHV1-69 anti-idiotypic antibody G6 and its Idiotope. Cell Rep 21:3243–3255CrossRef Avnir Y, Prachanronarong KL, Zhang Z et al (2017) Structural determination of the broadly reactive anti-IGHV1-69 anti-idiotypic antibody G6 and its Idiotope. Cell Rep 21:3243–3255CrossRef
Zurück zum Zitat Bendl J, Stourac J, Salanda O et al (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10:e1003440CrossRef Bendl J, Stourac J, Salanda O et al (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10:e1003440CrossRef
Zurück zum Zitat Berendsen HJC, Postma JPM, van Gunsteren WF et al (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690CrossRef Berendsen HJC, Postma JPM, van Gunsteren WF et al (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690CrossRef
Zurück zum Zitat Beutler E, Gelbart T, Kuhl W (1992) Mutations in Jewish patients with Gaucher disease. Blood 79(7):1662–1666PubMed Beutler E, Gelbart T, Kuhl W (1992) Mutations in Jewish patients with Gaucher disease. Blood 79(7):1662–1666PubMed
Zurück zum Zitat Brady RO, Kanfer J, Shapiro D (1965) The metabolism of glucocerebrosides. I.Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue. J Biol Chem 240:39–43PubMed Brady RO, Kanfer J, Shapiro D (1965) The metabolism of glucocerebrosides. I.Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue. J Biol Chem 240:39–43PubMed
Zurück zum Zitat Charrow J, Andersson HC, Kaplan P et al (2000) The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 160(18):2835–2843CrossRef Charrow J, Andersson HC, Kaplan P et al (2000) The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 160(18):2835–2843CrossRef
Zurück zum Zitat Clark LN, Ross BM, Wang Y et al (2007) Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69:1270–1277CrossRef Clark LN, Ross BM, Wang Y et al (2007) Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69:1270–1277CrossRef
Zurück zum Zitat Cormand B, Montfort M, Chabas A, Vilageliu L (1997) Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease. Hum Genet 100:75–79CrossRef Cormand B, Montfort M, Chabas A, Vilageliu L (1997) Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease. Hum Genet 100:75–79CrossRef
Zurück zum Zitat Dassault Systèmes BIOVIA (2016) Discovery Studio 2016, San Diego: Dassault Systèmes Dassault Systèmes BIOVIA (2016) Discovery Studio 2016, San Diego: Dassault Systèmes
Zurück zum Zitat Doss CGP, Alasmar DR, Bux RI et al (2016) Genetic epidemiology of Glucose-6-phosphate dehydrogenase deficiency in the Arab world. Sci Rep 6:37284CrossRef Doss CGP, Alasmar DR, Bux RI et al (2016) Genetic epidemiology of Glucose-6-phosphate dehydrogenase deficiency in the Arab world. Sci Rep 6:37284CrossRef
Zurück zum Zitat Duran R, Mencacci NE, Angeli AV et al (2013) The glucocerobrosidase E326K variant predisposes to Parkinson’s disease, but does not cause Gaucher’s disease. Mov Disord 28:232–236CrossRef Duran R, Mencacci NE, Angeli AV et al (2013) The glucocerobrosidase E326K variant predisposes to Parkinson’s disease, but does not cause Gaucher’s disease. Mov Disord 28:232–236CrossRef
Zurück zum Zitat Essmann U, Perera L, Berkowitz ML et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577CrossRef Essmann U, Perera L, Berkowitz ML et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577CrossRef
Zurück zum Zitat Fishbein I, Kuo Y-M, Giasson BI, Nussbaum RL (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain 137:3235–47CrossRef Fishbein I, Kuo Y-M, Giasson BI, Nussbaum RL (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain 137:3235–47CrossRef
Zurück zum Zitat Gan-Or Z, Amshalom I, Kilarski LL et al (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 84:880–887CrossRef Gan-Or Z, Amshalom I, Kilarski LL et al (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 84:880–887CrossRef
Zurück zum Zitat Gaucher PCE (1882) De l'epithelioma primitif de la rate, hypertrophie idiopathique del la rate san leucemie. MD thesis (Paris, France) Gaucher PCE (1882) De l'epithelioma primitif de la rate, hypertrophie idiopathique del la rate san leucemie. MD thesis (Paris, France)
Zurück zum Zitat Gegg ME, Burke D, Heales SJ et al (2012) Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains. Ann Neurol 72:455e463CrossRef Gegg ME, Burke D, Heales SJ et al (2012) Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains. Ann Neurol 72:455e463CrossRef
Zurück zum Zitat Gegg ME, Sweet L, Wang BH et al (2015) No evidence for substrate accumulation in Parkinson brains with GBA mutations. Mov Disord 30:1085–1089CrossRef Gegg ME, Sweet L, Wang BH et al (2015) No evidence for substrate accumulation in Parkinson brains with GBA mutations. Mov Disord 30:1085–1089CrossRef
Zurück zum Zitat George Priya Doss C, Zayed H (2017) Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metab Brain Dis 32:2105–2118CrossRef George Priya Doss C, Zayed H (2017) Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metab Brain Dis 32:2105–2118CrossRef
Zurück zum Zitat George Priya Doss C, Chakraborty C, Monford Paul Abishek N et al (2014) Application of evolutionary based in silico methods to predict the impact of single amino acid substitutions in vitelliform macular dystrophy. Adv Protein Chem Struct Biol 94:177–267 George Priya Doss C, Chakraborty C, Monford Paul Abishek N et al (2014) Application of evolutionary based in silico methods to predict the impact of single amino acid substitutions in vitelliform macular dystrophy. Adv Protein Chem Struct Biol 94:177–267
Zurück zum Zitat Goker-Alpan O, Schiffmann R, LaMarca ME, et al (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937–940CrossRef Goker-Alpan O, Schiffmann R, LaMarca ME, et al (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937–940CrossRef
Zurück zum Zitat Goker-Alpan O, Lopez G, Vithayathil J et al (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353–1357CrossRef Goker-Alpan O, Lopez G, Vithayathil J et al (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353–1357CrossRef
Zurück zum Zitat Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet 372:1263–1271CrossRef Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet 372:1263–1271CrossRef
Zurück zum Zitat Grantcharova VP, Riddle DS, Santiago JV et al (1998) Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain. Nat Struct Mol Biol 5:714–720CrossRef Grantcharova VP, Riddle DS, Santiago JV et al (1998) Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain. Nat Struct Mol Biol 5:714–720CrossRef
Zurück zum Zitat Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb viewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723CrossRef Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb viewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723CrossRef
Zurück zum Zitat Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472CrossRef Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472CrossRef
Zurück zum Zitat Hridya H, Amrita A, Mohan S et al (2016) Functionality study of santalin as tyrosinase inhibitor: a potential depigmentation agent. Int J Biol Macromol 86:383–389CrossRef Hridya H, Amrita A, Mohan S et al (2016) Functionality study of santalin as tyrosinase inhibitor: a potential depigmentation agent. Int J Biol Macromol 86:383–389CrossRef
Zurück zum Zitat Hruska KS, LaMarc ME, Scott CR et al (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567–583CrossRef Hruska KS, LaMarc ME, Scott CR et al (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567–583CrossRef
Zurück zum Zitat Keatinge M, Bui H, Menke A et al (2015) Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum Mol Genet 24:6640–6652CrossRef Keatinge M, Bui H, Menke A et al (2015) Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Hum Mol Genet 24:6640–6652CrossRef
Zurück zum Zitat Lesage S, Anheim M, Condroyer C et al (2011) Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson’s disease. Hum Mol Genet 20:202–210CrossRef Lesage S, Anheim M, Condroyer C et al (2011) Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson’s disease. Hum Mol Genet 20:202–210CrossRef
Zurück zum Zitat Lieberman RL, D'aquino JA, Ringe D et al (2009) Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry 48:4816–4827CrossRef Lieberman RL, D'aquino JA, Ringe D et al (2009) Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry 48:4816–4827CrossRef
Zurück zum Zitat Lobanov MI, Bogatyreva NS, Galzitskaia OV (2008) Radius of gyration is indicator of compactness of protein structure. Mol Biol (Mosk) 42:701–706CrossRef Lobanov MI, Bogatyreva NS, Galzitskaia OV (2008) Radius of gyration is indicator of compactness of protein structure. Mol Biol (Mosk) 42:701–706CrossRef
Zurück zum Zitat Magalhaes J, Gegg ME, Migdalska-Richards A et al (2016) Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson’s disease. Hum Mol Genet 25:3432–3445CrossRef Magalhaes J, Gegg ME, Migdalska-Richards A et al (2016) Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson’s disease. Hum Mol Genet 25:3432–3445CrossRef
Zurück zum Zitat Mao X, Wang T, Peng R et al (2013) Mutations in GBA and risk of Parkinson’s disease: a meta-analysis based on 25 case-control studies. Neurol Res 35:873–878CrossRef Mao X, Wang T, Peng R et al (2013) Mutations in GBA and risk of Parkinson’s disease: a meta-analysis based on 25 case-control studies. Neurol Res 35:873–878CrossRef
Zurück zum Zitat Meshach Paul D, Rajasekaran R (2017) In silico approach to explore the disruption in the molecular mechanism of human hyaluronidase 1 by mutant E268K that directs Natowicz syndrome. Eur Biophys J 46(2):157–169CrossRef Meshach Paul D, Rajasekaran R (2017) In silico approach to explore the disruption in the molecular mechanism of human hyaluronidase 1 by mutant E268K that directs Natowicz syndrome. Eur Biophys J 46(2):157–169CrossRef
Zurück zum Zitat Miyamoto S, Kollman PA (1992) Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952–962CrossRef Miyamoto S, Kollman PA (1992) Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952–962CrossRef
Zurück zum Zitat Mosaeilhy A, Mohamed MM, GPD C et al (2017) Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metab Brain Dis 32:1417–1426CrossRef Mosaeilhy A, Mohamed MM, GPD C et al (2017) Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metab Brain Dis 32:1417–1426CrossRef
Zurück zum Zitat Moseilhy A, Hassan MM, El Abd HSA et al (2017) Severe neurological manifestations in an Egyptian patient with a novel frameshift mutation in the Glutaryl-CoA dehydrogenase gene. Metab Brain Dis 32:35–40CrossRef Moseilhy A, Hassan MM, El Abd HSA et al (2017) Severe neurological manifestations in an Egyptian patient with a novel frameshift mutation in the Glutaryl-CoA dehydrogenase gene. Metab Brain Dis 32:35–40CrossRef
Zurück zum Zitat Nagasundaram N, C GPD, Chakraborty C et al (2016) Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials : An integrated computational approach. Nat Publ Gr 1–12 Nagasundaram N, C GPD, Chakraborty C et al (2016) Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials : An integrated computational approach. Nat Publ Gr 1–12
Zurück zum Zitat Naine SJ, Devi CS, Mohanasrinivasan V et al (2015) Binding and molecular dynamic studies of sesquiterpenes (2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol) derived from marine Streptomyces sp. VITJS8 as potential anticancer agent. Appl Microbiol Biotechnol 1–14 Naine SJ, Devi CS, Mohanasrinivasan V et al (2015) Binding and molecular dynamic studies of sesquiterpenes (2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol) derived from marine Streptomyces sp. VITJS8 as potential anticancer agent. Appl Microbiol Biotechnol 1–14
Zurück zum Zitat Offman MN, Krol M, Silman I et al (2010) Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S. J Biol Chem 285:42105–42114CrossRef Offman MN, Krol M, Silman I et al (2010) Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S. J Biol Chem 285:42105–42114CrossRef
Zurück zum Zitat P S, D KT, Tanwar H et al (2017) Structural analysis of G1691S variant in the human Filamin B gene responsible for Larsen syndrome: a comparative computational approach. J Cell Biochem 118:1900–1910CrossRef P S, D KT, Tanwar H et al (2017) Structural analysis of G1691S variant in the human Filamin B gene responsible for Larsen syndrome: a comparative computational approach. J Cell Biochem 118:1900–1910CrossRef
Zurück zum Zitat Pace CN, Fu H, Lee Fryar K et al (2014) Contribution of hydrogen bonds to protein stability. Protein Sci 23:652–661CrossRef Pace CN, Fu H, Lee Fryar K et al (2014) Contribution of hydrogen bonds to protein stability. Protein Sci 23:652–661CrossRef
Zurück zum Zitat Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190CrossRef Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190CrossRef
Zurück zum Zitat Petrova SS, Solov’ev AD (1997) The origin of the method of steepest descent. Hist Math 24:361–375CrossRef Petrova SS, Solov’ev AD (1997) The origin of the method of steepest descent. Hist Math 24:361–375CrossRef
Zurück zum Zitat Sahu VK, Khan AKR, Singh RK et al (2008) Hydrophobic, polar and hydrogen bonding based drug-receptor interaction of tetrahydroimidazobenzodiazepinones. Am J Immunol 4:33–42CrossRef Sahu VK, Khan AKR, Singh RK et al (2008) Hydrophobic, polar and hydrogen bonding based drug-receptor interaction of tetrahydroimidazobenzodiazepinones. Am J Immunol 4:33–42CrossRef
Zurück zum Zitat Sanchez-Martinez A, Beavan M, Gegg ME et al (2016) Parkinson’s disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models. Sci Rep 6:31380CrossRef Sanchez-Martinez A, Beavan M, Gegg ME et al (2016) Parkinson’s disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models. Sci Rep 6:31380CrossRef
Zurück zum Zitat Sanders A, Hemmelgarn H, Melrose HL et al (2013) Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease. Blood Cells Mol Dis 51:109–115CrossRef Sanders A, Hemmelgarn H, Melrose HL et al (2013) Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease. Blood Cells Mol Dis 51:109–115CrossRef
Zurück zum Zitat Sardi SP, Cheng SH, Shihabuddin LS (2015) Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle. Prog Neurobiol 125:47–62CrossRef Sardi SP, Cheng SH, Shihabuddin LS (2015) Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle. Prog Neurobiol 125:47–62CrossRef
Zurück zum Zitat Schmid N, Eichenberger AP, Choutko A et al (2011) Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40:843–856CrossRef Schmid N, Eichenberger AP, Choutko A et al (2011) Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40:843–856CrossRef
Zurück zum Zitat Schneider JP, Kelly JW (1995) Templates that Induce .Alpha.-helical, .Beta.-sheet, and loop conformations. Chem Rev 95:2169–2187CrossRef Schneider JP, Kelly JW (1995) Templates that Induce .Alpha.-helical, .Beta.-sheet, and loop conformations. Chem Rev 95:2169–2187CrossRef
Zurück zum Zitat Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of Glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 361:1651–1661CrossRef Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of Glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 361:1651–1661CrossRef
Zurück zum Zitat Sievers F, Higgins DG (2014) Clustal omega, accurate alignment of very large numbers of sequences. Methods Mol Biol 1079:105–116 Sievers F, Higgins DG (2014) Clustal omega, accurate alignment of very large numbers of sequences. Methods Mol Biol 1079:105–116
Zurück zum Zitat Smith L, Mullin S, Schapira AHV (2017) Insights into the structural biology of Gaucher disease. Exp Neurol 298(Pt B):180–190CrossRef Smith L, Mullin S, Schapira AHV (2017) Insights into the structural biology of Gaucher disease. Exp Neurol 298(Pt B):180–190CrossRef
Zurück zum Zitat Sneha P, Priya Doss CG (2016) Molecular dynamics: new frontier in personalized medicine. Adv Protein Chem Struct Biol 102:181–224 Sneha P, Priya Doss CG (2016) Molecular dynamics: new frontier in personalized medicine. Adv Protein Chem Struct Biol 102:181–224
Zurück zum Zitat Sneha P, Thirumal KD, George PDC et al (2017a) Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: a computational approach. PLoS One 12:1–24 Sneha P, Thirumal KD, George PDC et al (2017a) Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: a computational approach. PLoS One 12:1–24
Zurück zum Zitat Sneha P, Thirumal Kumar D, Saini S et al (2017b) Analyzing the effect of V66M mutation in BDNF in causing mood disorders: a computational approach. Adv Protein Chem Struct Biol 108:85–103 Sneha P, Thirumal Kumar D, Saini S et al (2017b) Analyzing the effect of V66M mutation in BDNF in causing mood disorders: a computational approach. Adv Protein Chem Struct Biol 108:85–103
Zurück zum Zitat Sujitha SP, Kumar DT, Doss CGP et al (2016) DNA repair gene (XRCC1) polymorphism (Arg399Gln) associated with schizophrenia in south Indian population: a genotypic and molecular dynamics study. PLoS One 11:e0147348CrossRef Sujitha SP, Kumar DT, Doss CGP et al (2016) DNA repair gene (XRCC1) polymorphism (Arg399Gln) associated with schizophrenia in south Indian population: a genotypic and molecular dynamics study. PLoS One 11:e0147348CrossRef
Zurück zum Zitat Tanwar H, Sneha P, Thirumal Kumar D et al (2017) A computational approach to identify the biophysical and structural aspects of methylenetetrahydrofolate reductase (MTHFR) mutations (A222V, E429A, and R594Q) leading to Schizophrenia. Adv Protein Chem Struct Biol 108:105–125 Tanwar H, Sneha P, Thirumal Kumar D et al (2017) A computational approach to identify the biophysical and structural aspects of methylenetetrahydrofolate reductase (MTHFR) mutations (A222V, E429A, and R594Q) leading to Schizophrenia. Adv Protein Chem Struct Biol 108:105–125
Zurück zum Zitat Tayebi N, Walker J, Stubblefield B, et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104–9CrossRef Tayebi N, Walker J, Stubblefield B, et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104–9CrossRef
Zurück zum Zitat Thirumal Kumar D, George Priya Doss C, Sneha P et al (2016) Influence of V54M mutation in giant muscle protein titin: a computational screening and molecular dynamics approach. J Biomol Struct Dyn 1102:1–12CrossRef Thirumal Kumar D, George Priya Doss C, Sneha P et al (2016) Influence of V54M mutation in giant muscle protein titin: a computational screening and molecular dynamics approach. J Biomol Struct Dyn 1102:1–12CrossRef
Zurück zum Zitat Thirumal Kumar D, George Priya Doss C, Sneha P et al (2017a) Influence of V54M mutation in giant muscle protein titin: a computational screening and molecular dynamics approach. J Biomol Struct Dyn 35:917–928CrossRef Thirumal Kumar D, George Priya Doss C, Sneha P et al (2017a) Influence of V54M mutation in giant muscle protein titin: a computational screening and molecular dynamics approach. J Biomol Struct Dyn 35:917–928CrossRef
Zurück zum Zitat Ullah I, Nasir A, Mehmood S et al (2017) Identification and in silico analysis of GALNS mutations causing Morquio a syndrome in eight consanguineous families. Turk J Biol 41:458–468CrossRef Ullah I, Nasir A, Mehmood S et al (2017) Identification and in silico analysis of GALNS mutations causing Morquio a syndrome in eight consanguineous families. Turk J Biol 41:458–468CrossRef
Zurück zum Zitat Wei RR, Hughes H, Boucher S et al (2011) X-ray and biochemical analysis of N370S mutant human acid β-glucosidase. J Biol Chem 286:299–308CrossRef Wei RR, Hughes H, Boucher S et al (2011) X-ray and biochemical analysis of N370S mutant human acid β-glucosidase. J Biol Chem 286:299–308CrossRef
Zurück zum Zitat Xu YH, Quinn B, Witte D et al (2003) Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 163:2093–2101CrossRef Xu YH, Quinn B, Witte D et al (2003) Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol 163:2093–2101CrossRef
Zurück zum Zitat Yagawa K, Yamano K, Oguro T et al (2010) Structural basis for unfolding pathway-dependent stability of proteins: Vectorial unfolding versus global unfolding. Protein Sci 19:693–702CrossRef Yagawa K, Yamano K, Oguro T et al (2010) Structural basis for unfolding pathway-dependent stability of proteins: Vectorial unfolding versus global unfolding. Protein Sci 19:693–702CrossRef
Zurück zum Zitat Zaki OK, El Abd HS, Mohamed SA et al (2016) Novel mutation in an Egyptian patient with infantile Canavan disease. Metab Brain Dis 31:573–577CrossRef Zaki OK, El Abd HS, Mohamed SA et al (2016) Novel mutation in an Egyptian patient with infantile Canavan disease. Metab Brain Dis 31:573–577CrossRef
Zurück zum Zitat Zaki OK, Krishnamoorthy N, El Abd HS et al (2017a) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32:171–177CrossRef Zaki OK, Krishnamoorthy N, El Abd HS et al (2017a) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32:171–177CrossRef
Zurück zum Zitat Zaki OK, Priya Doss CG, Ali SA et al (2017b) Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants. Hum Mol Genet 12:e0174953 Zaki OK, Priya Doss CG, Ali SA et al (2017b) Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants. Hum Mol Genet 12:e0174953
Zurück zum Zitat Zuckerman S, Lahad A, Shmueli A et al (2007) Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases. JAMA 298(11):1281–1290CrossRef Zuckerman S, Lahad A, Shmueli A et al (2007) Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases. JAMA 298(11):1281–1290CrossRef
Metadaten
Titel
Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases
verfasst von
D. Thirumal Kumar
Hend Ghasan Eldous
Zainab Alaa Mahgoub
C. George Priya Doss
Hatem Zayed
Publikationsdatum
06.07.2018
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 6/2018
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-018-0286-3

Weitere Artikel der Ausgabe 6/2018

Metabolic Brain Disease 6/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.